Background: Most children with cancer live in resource-limited countries where malnutrition is often prevalent. We identified the relationship between malnutrition and treatment-related morbidity (TRM), abandonment of therapy, and survival of children with cancer in Nicaragua to better inform targeted nutritional interventions. vs. 5.58 years; P = 0.049), and abandoned therapy more frequently (P = 0.015).
INTRODUCTION
Of the 160,000 children and adolescents around the world in whom cancer is diagnosed each year, 80% live in low-or middle-income countries (LMICs) where access to curative treatment is limited. 1 By the end of this decade, it is predicted that pediatric cancer cases will increase by 30% in LMICs. 1 Survival of childhood cancer in those countries is Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BL, Burkitt lymphoma; BMI, body mass index; CTCAE, common terminology criteria for adverse events; EFS, event-free survival; LMIC, low-and middle-income country; MUAC, mid-upper arm circumference; POND, pediatric oncology network database; TRM, treatment-related morbidity; TSFT, triceps skin-fold thickness; WHO, world health organization only about 25%, compared to nearly 80% in high-income countries 2 despite advances in treatment of diseases such as Burkitt lymphoma (BL) in some LMICs. 3 Malnutrition is a negative prognostic factor that is often associated with increased morbidity and/or decreased survival in pediatric oncology patients, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] with few exceptions. 16 In Nicaragua, where UNICEF estimates that 6% of children younger than 5 years are moderately to severely underweight and 22% suffer from moderate to severe stunting, this issue is particularly relevant. 17 Cancer confers an additional risk of malnutrition due to increased metabolic rate, anorexia, inflammation, and altered physical activity. 18 Studies in Central America, Morocco, and Malawi have demonstrated high rates of malnutrition (20-59%) in children at the time of cancer diagnosis. 10, 11, 15, 19, 20 Moreover, malnutrition varies widely by disease type. In Central America, Sala et al. found that the proportion of underweight patients varied significantly by type of cancer, keeping with findings in high-income countries. 11 For example, in a review of 11 observational studies, Brinksma et al. found that 5-10% of children with leukemia were malnourished compared to 50% of those with neuroblastoma. 18 Beyond its effect on survival, malnutrition in pediatric oncology patients is associated with treatment delays, 21 increased risk of infection, 6, 13, 22, 23 impaired wound healing, 24 lower quality of life, 4 and inferior treatment tolerance and response. 14, [25] [26] [27] [28] [29] Unfortunately, there is no universally accepted algorithm for assessing malnutrition in pediatric oncology patients. 30, 31 In 2008, the Children's Oncology Group Nutrition Committee published categories of nutritional status and an algorithm for nutritional intervention based on body mass index (BMI), weight for length or height, or percentile ideal body weight for height or length. 32 Normative data for BMI of persons as old as 19 years is available from the World Health Organization (WHO) Child Growth Standards, 33 and patients have weight and height information routinely collected to calculate body surface area for chemotherapy dosing.
Reliance on weight measurement can be misleading, however, because some children have a large tumor mass (at times >10% of body weight), ascites, or substantial peripheral edema related to malignancy, malnutrition, and/or hypoalbuminemia. 34, 35 In the setting of inadequate energy supply, nutritional reserves stored in the form of skeletal muscle protein and fat are used first, which is reflected by an earlier decline in mid-upper arm circumference (MUAC) and triceps skin-fold thickness (TSFT). 35 Multiple authors conclude that MUAC and TSFT are acceptable surrogate measures of lean body mass and fat mass, respectively, as they are independent of ethnicity, not influenced directly by large tumor mass, and correlate with body composition. 11, 12, 32, [34] [35] [36] [37] [38] [39] In a large prospective study in Central America, Sala et al. concluded that there is also considerable added value to the inclusion of serum albumin in categories of nutritional status. 11 In resource-limited settings, providing nutritional support to all children with cancer may not be possible. The literature suggests key differences in the degree of malnutrition and its impact on survival among patients with different childhood malignancies and among countryspecific populations. We aimed to describe the relationship between malnutrition and treatment-related morbidity (TRM), abandonment of therapy, and survival of children with cancer in Nicaragua to identify the subgroups most at risk and better inform targeted nutritional interventions.
METHODS

Study design and data collection
We conducted a retrospective study of patients, aged 6 months to 
Statistical analysis
Patients were grouped by cancer type, nutritional status at diagnosis, and risk category (low/standard or high) for analysis. Tests of independence were performed using the Pearson chi-square for 
RESULTS
A total of 473 patients were retrospectively reviewed, and 282 patients were included in the study (Fig. 2 ). There were slightly more male patients (58.5%) than female patients (41.5%; Table 1 ).
The median age at diagnosis was 7.13 years (range, 0.5-16.25 years; interquartile range, 4.1-11.6). The majority (98%) of patients were younger than 15 years; 5% were younger than 2 years, and 2% were younger than 1 year. Patients with ALL comprised the largest group (68.4%), followed by those with AML (12.4%), Hodgkin lymphoma (8.5%), BL (5.7%), and Wilms tumor (5%). Overall, 72.3% of patients had high-risk disease, based on disease stage or risk group (Table 1) . Cancer type was significantly associated with EFS at 2 years (P < 0.01), and the poorest outcomes were seen in patients with AML (22.9%) or Wilms tumor (35.7%; Table 1 ). Disease relapse/progression was the leading cause of death (70.3%; 83/118) during the study period, followed by infection (22.9%; 27/188) and hemorrhage (4.3% 5/118). Table 2 shows the distribution of nutritional status among patients by disease type. On the basis of the categories of nutritional status (Fig. 1) , 67% of patients were classified as malnourished at diagnosis (19.1% had moderate malnutrition; 47.9% had severe malnutrition). Examining the proportion of days (<25%, 25-50%, 50-75%, or >75%) on which patients experienced grade 3 or worse toxicity during the first 90 days of treatment, we found greater morbidity in children with severe malnutrition versus adequate nutrition (P = 0.023;
Supplementary Table S1 ). The distribution of percent days with grade 3 or worse toxicity also differed significantly across cancer types (P < 0.001). Severely malnourished patients were more likely to experience severe morbidity on more than 50% of days (P = 0. with significance across the distribution (P = 0.049). At 2 years, nutritional status (adequate vs. inadequate) at diagnosis was significantly associated with treatment abandonment (P = 0.015), but not relapse or death (P = 0.32; Table 3 ). EFS, event-free survival. a Nutritional status was significantly associated with treatment abandonment at 2 years (P = 0.015).
DISCUSSION
likely due to small sample size. Prevalence of malnutrition in patients with newly diagnosed BL was similar to that in patients with AML and should also be considered among the most at risk groups. Furthermore, we observed a tendency toward higher rates of malnutrition among patients with high-risk disease across all cancer types, which is also reported in high-income countries and can be attributed to disease burden. Patients with high-risk disease require the most intensive therapy and therefore have a compounded risk of TRM. Notably, the majority of Wilms tumor patients had high-risk disease at diagnosis and all of these patients (85.7%) were malnourished, contributing to the strikingly poor outcome of these patients as compared to that observed in high-income countries. Late diagnosis often observed in LMICs leads to a greater proportion of patients with advanced disease, related malnutrition, and inferior outcomes compared to high-income countries.
Although previous studies have examined the cause of death or specific toxicities, we examined the relations between nutritional status and TRM as a whole within a systematic framework. As expected, there was a significant relation between grade 3 or worse toxicity and severe versus adequate nutritional status, highlighting substantial morbidity. A key finding in this study was the association between clinically severe infection (≥grade 3) and nutritional status, as infection is a well-recognized cause of mortality and the second leading cause of death during the study period (22.9%). Increasing survival in low-income countries most likely will not be possible without concurrent advances in supportive care, most notably infection control. 2, 45 Addressing malnutrition, an important yet often neglected area of supportive care, could be another approach to potentially prevent infection and improve survival.
One limitation of our small sample size was the lack of statistical power to examine differences in TRM within cancers and stage/risk groups, as related to nutritional status. However, previous studies examining individual toxicities within one disease suggest that the same trend of increased toxicity with inferior nutritional status holds true. For example, malnourished patients with Wilms tumors in Malawi exhibit lower vincristine clearance rates and thus higher area-underthe-curve values than does a comparable patient population with a better nutritional status in the United Kingdom, suggesting the need for dose reductions in malnourished patients to prevent toxicity. 46 Moreover, patients with BL in Malawi who were acutely malnourished at diagnosis had a significantly higher rate of profound neutropenia during chemotherapy, underscoring the need for careful evaluation of the association between malnutrition and chemotherapy-induced toxicities. 14 We examined the relations between malnutrition at diagnosis and 20 A prospective study monitoring toxicity and nutritional status over the duration of therapy to further explore these relations may help identify the patients at greatest risk of TRM and most likely to benefit from nutritional intervention.
Overall, malnutrition was an adverse prognostic factor associated with inferior EFS, which supports the findings from most previous studies [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and underscores the importance of evaluating all patients at diagnosis and prospectively. Together, these findings suggest that in resource-limited settings priority for nutritional interventions could be given to the most vulnerable populations (e.g., pediatric patients with high-risk solid tumors, AML, or BL) to improve outcomes.
Targeted nutritional interventions for high-risk groups can improve morbidity and mortality as demonstrated in Malawi, where a high rate of acute malnutrition was found in patients with Wilms tumor at diagnosis (45-55%). 47 When these children were given chiponde, a peanut butter-based ready-to-eat therapeutic food, 7 of 18 had a greater than 5% increase in corrected weight during preoperative chemotherapy and those with a positive nutritional course had a better tumor response to chemotherapy. 47 Similar nutritional supplements already exist in Central America and should be readily available. 48 In Guatemala, patients with ALL who demonstrated improvement in nutritional status from severely depleted to adequate at 6 months from diagnosis had similar 5-year overall survival to children not presenting with nutritional depletion. 20 Simple, cost-effective nutritional interventions could potentially counter the effect of toxicity, particularly infection and treatment tolerance, thereby leading to improved treatment response and overall survival.
In conclusion, malnutrition was associated with increased TRM, specifically severe infection, and worse overall outcome among pedi- 
